Release of LPL activity after intravenous injection of a low molecular weight heparin.

A low molecular weight heparin (MW 4000-6000), PK 10169 (Pharmuka), with much reduced anticoagulant in vitro capacity, retains the properties of the standard heparin in releasing lipoprotein lipase and hepatic lipase activity after being injected intravenously.